LEO Pharma, a parent company of Timber Pharmaceuticals, Inc., presents initial findings from the ASCEND trial in a late-breaking session at the 2024 American Academy of Dermatology (AAD) Annual Meeting.…
Incyte (Nasdaq:INCY) disclosed findings from a Phase 2 trial examining povorcitinib (INCB54707), an oral JAK1 inhibitor’s effectiveness and safety among adult patients with prurigo nodularis (PN). These results were presented…
Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, has announced positive results from the Phase 2 KARDIA-2 trial of zilebesiran, an RNAi therapeutic designed to treat hypertension by…
GenSight Biologics (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a prominent biopharmaceutical company specializing in innovative gene therapies for retinal neurodegenerative diseases and central nervous system disorders, has disclosed recent prospective…
In Tokyo, Japan-Ukraine Conference Focuses on Economic Development and Reconstruction Representatives from Japanese and Ukrainian governments and business organizations gathered in Tokyo on February 19 for the Japan-Ukraine Conference on…
The latest addition to ResearchAndMarkets.com’s offerings is the ‘Global Monkeypox Diagnostics Market by Assay, Country, Product, and Place, featuring Executive & Consultant Guides, along with Market Analysis & Forecasts for…
Pinnacle Treatment Centers, a leading provider of affordable, accessible substance use disorder treatment services, is thrilled to announce the recent hire of Dr. Chris Yadron, Ph.D., LCPC, CADC, as the…
REVEAL GENOMICS, S.L., a pioneering biotechnology start-up based in Barcelona that is poised to transform precision oncology with its biomarker innovations, has announced the start of the DEFINITIVE study, led…
Today, Exact Sciences Corp., renowned for its cancer screening and diagnostic solutions, unveiled the introduction of the Riskguard™ hereditary cancer test across the United States. This innovative test furnishes personalized…
Orca Bio, a biotech firm advancing precise cell therapies for cancer, autoimmune disorders, and genetic blood conditions, has unveiled promising results for its lead investigational therapy, Orca-T, at the 2024…
The College of American Pathologists (CAP) updated the “Principles of Analytic Validation of Immunohistochemical Assays” guideline to provide increased precision and accuracy of clinical immunohistochemical assays. This update assesses evidence…
The MANDARA Phase III trial published in the New England Journal of Medicine and presented at the AAAAI Annual Meeting reveals promising outcomes for FASENRA® (benralizumab) in treating EGPA. This…
